Tobacco Industry Efforts Undermining Evidence Linking Secondhand Smoke With Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background— The scientific consensus that secondhand smoke (SHS) increases cardiovascular disease (CVD) risk by 30% is based on epidemiological and biological evidence. The tobacco industry has contested this evidence that SHS causes CVD, but how and why they have done it has not been described. Methods and Results— About 50 million pages of tobacco industry documents were searched using general keywords and names of industry consultants and scientists. Tobacco industry–funded epidemiological analyses of large data sets were used to argue against an epidemiological association between SHS and CVD and smoke-free regulations, but these analyses all suffered from exposure misclassification problems that biased the results toward the null. More recent industry-funded publications report an increased risk of CVD associated with SHS but claim a low magnitude of risk. When early tobacco industry–funded work demonstrated that SHS increased atherosclerosis, the industry criticized the findings and withdrew funding. RJ Reynolds focused on attacking the biological plausibility of the association between SHS and CVD by conducting indirect platelet aggregation studies, exposure chamber experiments, and literature reviews. Although these studies also suffered from exposure misclassification problems, several produced results that were consistent with a direct effect of SHS on blood and vascular function. Instead, RJ Reynolds attributed these results to an unproven epinephrine-related stress response from odor or large smoke exposure, which supported their regulatory and “reduced-harm” product development efforts. Philip Morris’ recent “reduced-harm” efforts seem supportive of a similar corporate agenda. Conclusions— The tobacco industry attempted to undermine the evidence that SHS causes CVD to fight smoke-free regulations while developing approaches to support new products that claim to reduce harm. The industry interest in preserving corporate viability has affected the design and interpretation of their cardiovascular studies, indicating the need for great caution in current debates about future tobacco industry regulation and development of reduced-harm tobacco products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of smoke-free workplaces on smoking behaviour: systematic review
Fichtenberg, C. M., & Glantz, S. A. (2002) · BMJ · doi:10.1136/bmj.325.7357.188 · Cited by 1,072
Self-citationCardiovascular Effects of Secondhand Smoke: Nearly as Large as Smoking
Barnoya, J., & Glantz, S. A. (2005) · Circulation · doi:10.1161/circulationaha.104.492215 · Cited by 939
Self-citationEnvironmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence
Law, M. R., Morris, J. K., & Wald, N. J. (1997) · BMJ · doi:10.1136/bmj.315.7114.973 · Cited by 604
Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm
Raupach, T., Schäfer, K., Konstantinides, S., & Andreas, S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi601 · Cited by 251
Constructing “Sound Science” and “Good Epidemiology”: Tobacco, Lawyers, and Public Relations Firms
Ong, E. K., & Glantz, S. A. (2001) · American Journal of Public Health · doi:10.2105/ajph.91.11.1749 · Cited by 243
Self-citationBarone-Adesi, F., Vizzini, L., Merletti, F., & Richiardi, L. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl201 · Cited by 240
Barnes, D. E., & Bero, L. A. (1996) · Journal of Health Politics, Policy and Law · doi:10.1215/03616878-21-3-515 · Cited by 176
The impact of a smoking ban on hospital admissions for coronary heart disease
Khuder, S. A., Milz, S., Jordan, T., Price, J., Silvestri, K., & Butler, P. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.03.011 · Cited by 152
Tobacco Industry Influence on Science and Scientists in Germany
Grüning, T., Gilmore, A. B., & McKee, M. (2006) · American Journal of Public Health · doi:10.2105/ajph.2004.061507 · Cited by 122
Bornhäuser, A., McCarthy, J., & Glantz, S. A. (2006) · Tobacco Control · doi:10.1136/tc.2005.012336 · Cited by 52
Self-citation
Cited by
The Perils of Ignoring History: Big Tobacco Played Dirty and Millions Died. How Similar Is Big Food?
BROWNELL, K. D., & WARNER, K. E. (2009) · The Milbank Quarterly · doi:10.1111/j.1468-0009.2009.00555.x · Cited by 678
Parkhurst, J. (2016) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · doi:10.4324/9781315675008 · Cited by 756
Smoke-free spaces: a decade of progress, a need for more?
Semple, S., Dobson, R., O'Donnell, R., Zainal Abidin, E., Tigova, O., Okello, G., & Fernández, E. (2022) · Tobacco Control · doi:10.1136/tobaccocontrol-2021-056556 · Cited by 62
Kern, J. K., Geier, D. A., Deth, R. C., Sykes, L. K., Hooker, B. S., Love, J. M., Bjørklund, G., Chaigneau, C. G., Haley, B. E., & Geier, M. R. (2017) · Science and Engineering Ethics · doi:10.1007/s11948-017-9983-2 · Cited by 14
Retracted
Metadata
- Authors
- Tong, E. K., & Glantz, S. A.
- Venue
- Circulation
- Published
- 2007-10-16
- Volume
- 116
- Issue
- 16
- Pages
- 1845-1854
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2156041668
- Cited by
- 80
- References
- 10
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.